Falcucci, Paolo
 Distribuzione geografica
Continente #
EU - Europa 196
NA - Nord America 137
AS - Asia 50
AF - Africa 1
Totale 384
Nazione #
US - Stati Uniti d'America 135
DE - Germania 133
CN - Cina 27
SE - Svezia 15
FR - Francia 12
UA - Ucraina 12
GB - Regno Unito 9
SG - Singapore 9
IE - Irlanda 7
IN - India 6
FI - Finlandia 4
ID - Indonesia 3
CA - Canada 2
HK - Hong Kong 2
IT - Italia 2
TR - Turchia 2
CI - Costa d'Avorio 1
ES - Italia 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
Totale 384
Città #
Chandler 25
Ashburn 10
Jacksonville 9
Nürnberg 8
Ann Arbor 7
San Mateo 7
Dearborn 6
Dublin 6
Nanjing 6
Redwood City 6
Singapore 6
Beijing 5
Leawood 5
Lancaster 4
Munich 4
Bremen 3
Jakarta 3
Los Angeles 3
Marseille 3
Shenyang 3
Boston 2
Catania 2
Chicago 2
Hong Kong 2
Lawrence 2
Mountain View 2
New York 2
Toronto 2
Wilmington 2
Woodbridge 2
Abidjan 1
Auburn Hills 1
Boardman 1
Cambridge 1
Fairfield 1
Guangzhou 1
Hebei 1
Helsinki 1
Houston 1
Indiana 1
Izmir 1
Jining 1
Kunming 1
London 1
Mersin 1
Monmouth Junction 1
Moscow 1
Nanchang 1
Nashville 1
Ningbo 1
Norwalk 1
Paris 1
Princeton 1
Riyadh 1
Santa Clara 1
Seattle 1
Simi Valley 1
University Park 1
Wuhan 1
Zhengzhou 1
Totale 179
Nome #
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome 149
The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. 126
All-trans retinoic acid in association with low dose cytosine arabinoside in the treatment of acute myeoid leukemia in elderly patients 111
Totale 386
Categoria #
all - tutte 1.134
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.134


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202038 0 0 0 0 0 0 4 9 1 7 14 3
2020/202143 1 4 4 3 5 7 3 1 5 0 10 0
2021/202241 5 4 3 1 0 2 3 6 1 2 8 6
2022/202366 8 13 4 7 14 5 4 4 6 0 1 0
2023/202429 2 9 0 1 0 5 4 0 0 1 5 2
2024/202519 0 0 3 2 9 5 0 0 0 0 0 0
Totale 386